TMCnet News

Nephros Names Daron Evans to Board of Directors [Health & Beauty Close - Up]
[December 04, 2013]

Nephros Names Daron Evans to Board of Directors [Health & Beauty Close - Up]


(Health & Beauty Close - Up Via Acquire Media NewsEdge) Nephros, Inc., a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, announced the appointment of Daron Evans to its Board of Directors.



According to a release, Evans replaces James S. Scibetta who will be leaving the Board. Evans was also named a member of the Audit Committee.

Evans is a life sciences executive with over 20 years of financial leadership and operational experience, the company noted. Evans is currently a Partner at The Highland Group, an operational consulting practice that partners with industrial clients to deliver targeted results, and a Director on the Board of Zumbro Discovery, an early stage company developing a novel therapy for resistant hypertension. Evans was most recently Chief Financial Officer of Nile Therapeutics, Inc., from 2007 until its merger with Capricor, Inc. in November 2013. From 2006 to 2007, he was Director of Business Assessment for Vistakon, a division of Johnson & Johnson Corp. From 2004 to 2006, he was Associate Director of Portfolio Mgmt & Business Analytics at Scios, Inc. after its acquisition by Johnson & Johnson Corp. Evans was a co-founder of Applied Neuronal Network Dynamics, Inc. and served as its President from 2002 to 2004. From 1995 to 2002, Evans served in various roles at consulting firms Arthur D. Little and Booz Allen & Hamilton. Evans is the author of four U.S. patents.


"I am very pleased to welcome Daron to Nephros' Board of Directors," stated John C. Houghton, CEO of Nephros. "Daron's extensive operational and business development experience will be a welcome complement to the Board." "I am very impressed with the Nephros team and the wide range of commercial opportunities for the company's products," stated Evans. "I look forward to being an active member of the Board as Nephros seeks to capitalize on these opportunities." More information: www.nephros.com ((Comments on this story may be sent to [email protected])) (c) 2013 ProQuest Information and Learning Company; All Rights Reserved.

[ Back To TMCnet.com's Homepage ]